News
SYGGF
0.014
NaN%
--
Weekly Report: what happened at SYGGF last week (0406-0410)?
Weekly Report · 3d ago
Weekly Report: what happened at SYGGF last week (0330-0403)?
Weekly Report · 04/06 10:05
Weekly Report: what happened at SYGGF last week (0323-0327)?
Weekly Report · 03/30 10:05
Weekly Report: what happened at SYGGF last week (0316-0320)?
Weekly Report · 03/23 10:01
Weekly Report: what happened at SYGGF last week (0309-0313)?
Weekly Report · 03/16 10:01
Weekly Report: what happened at SYGGF last week (0302-0306)?
Weekly Report · 03/09 10:02
Weekly Report: what happened at SYGGF last week (0223-0227)?
Weekly Report · 03/02 10:01
Weekly Report: what happened at SYGGF last week (0216-0220)?
Weekly Report · 02/23 10:01
Weekly Report: what happened at SYGGF last week (0209-0213)?
Weekly Report · 02/16 10:01
Weekly Report: what happened at SYGGF last week (0202-0206)?
Weekly Report · 02/09 10:02
Weekly Report: what happened at SYGGF last week (0126-0130)?
Weekly Report · 02/02 10:02
Weekly Report: what happened at SYGGF last week (0119-0123)?
Weekly Report · 01/26 10:02
Weekly Report: what happened at SYGGF last week (0112-0116)?
Weekly Report · 01/19 10:07
Weekly Report: what happened at SYGGF last week (0105-0109)?
Weekly Report · 01/12 10:06
Weekly Report: what happened at SYGGF last week (1229-0102)?
Weekly Report · 01/05 10:01
Weekly Report: what happened at SYGGF last week (1222-1226)?
Weekly Report · 12/29/2025 10:01
Weekly Report: what happened at SYGGF last week (1215-1219)?
Weekly Report · 12/22/2025 10:01
Weekly Report: what happened at SYGGF last week (1208-1212)?
Weekly Report · 12/15/2025 10:06
Weekly Report: what happened at SYGGF last week (1201-1205)?
Weekly Report · 12/08/2025 10:05
Weekly Report: what happened at SYGGF last week (1124-1128)?
Weekly Report · 12/01/2025 10:01
More
Webull provides a variety of real-time SYGGF stock news. You can receive the latest news about Synairgen Plc through multiple platforms. This information may help you make smarter investment decisions.
About SYGGF
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.